Posted inBiotechnology
Treatment Goals Shape Outcomes in Critically Ill Nonagenarians
In the evolving landscape of geriatric critical care, a groundbreaking study has shed new light on the nuanced relationship between…
Posted inBiotechnology
Radiofrequency Cascade Unlocks Coupled Spin Qubit Readout
In a groundbreaking advance in quantum information processing, researchers have unveiled a novel radiofrequency (rf) electron-cascade readout technique that significantly…
Posted inGenetics
Lilly Grows AI Footprint with Up-to-$2.75B Insilico Collaboration
Eli Lilly and Insilico Medicine are expanding a three-year partnership with a discovery and development collaboration that could generate more than $2.75 billion for the AI-based drug developer,…
Posted inBiotechnology
Kevin Tang uses newfound control of Aurinia to finally take over Kezar
After being knocked back in 2024, serial biotech acquirer Kevin Tang has used a different route to finally get his…
Posted inMedical Technology
Boston Scientific’s Watchman heart implant measures up to blood thinners in ACC trial
In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that…
Posted inBiotechnology
J&J secures Royalty backing for $500M autoimmune antibody program
Royalty Pharma has made another play in the autoimmune space, this time crowning Johnson & Johnson as the beneficiary. Royalty…
Posted inBiotechnology
Scientists Discover the Most Prevalent Recessive Neurodevelopmental Disorder to Date
In a groundbreaking advancement that reshapes our understanding of neurodevelopmental disorders, a research team at the Icahn School of Medicine…
Posted inBiotechnology
Quantum Researchers Develop Ultra-Precise Phonon Lasers
In the realm of laser technology, the advent of the conventional laser in the 1960s marked a pivotal breakthrough, enabling…
Posted inBiotechnology
Squid Evolution Ignited 100 Million Years Ago in Deep Ocean, Triggering Rapid Diversification
Squid and cuttlefish have long captured the imagination of scientists and marine enthusiasts alike with their stunning abilities—from rapid skin…
Posted inBiotechnology
Connect’s Dupixent challenger hits the mark in phase 3 eczema trial
Connect Biopharma has reported 52-week improvements across multiple endpoints in a phase 3 trial of its eczema drug candidate, fueling the…